For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250108:nRSH6084Sa&default-theme=true
RNS Number : 6084S AVI Global Trust PLC 08 January 2025
AVI GLOBAL TRUST PLC
Monthly Update
AVI Global Trust plc (the "Company") presents its Update, reporting
performance figures for the month ended 31 December 2024.
This Monthly Newsletter is available on the Company's website at:
AGT-DECEMBER-2024.pdf
(https://www.assetvalueinvestors.com/content/uploads/2025/01/AGT-DECEMBER-2024.pdf?mc_cid=735ee5375f&mc_eid=b2f1940a8e)
This investment management report relates to performance figures to 31
December 2024.
Total Return (£) Month Calendar Yr 1Y 3Y 5Y 10Y
to date
AGT NAV 1.7% 10.4% 10.4% 19.8% 68.2% 175.6%
MSCI ACWI -0.9% 19.6% 19.6% 26.8% 70.8% 201.1%
MSCI ACWI ex US -0.5% 7.4% 7.4% 10.8% 29.3% 99.0%
Manager's Comment
AVI Global Trust (AGT)'s NAV increased +1.7% in December.
D'Ieteren, Chrysalis and Harbourvest were the top contributors, adding
+113bps, +76bps and +37bps to returns, respectively.
Entain detracted -57bps following the announcement of legal proceedings
against the company in Australia, whilst News Corp and Frasers shaved off
-43bps and - 30bps. In the case of Frasers, this followed a relatively modest
(-4% at the mid-point) cut to full year guidance which has pushed the shares
down -17% over the month. We added to the position.
D'Ieteren
D'Ieteren was the most significant contributor to performance over the month,
adding +113bps to NAV as the position returned +13%.
As highlighted in September's
(https://www.assetvalueinvestors.com/content/uploads/2024/10/AGT-SEPTEMBER-2024.pdf)
letter, last Autumn the company announced an extraordinary €74 per share
special dividend, equivalent to 39% of the company's market cap at the time.
Selling pressure from tax-sensitive investors - who faced Belgian Withholding
Tax rates of up to 30% vs. AGT's 10% net rate - pushed the shares down from
€226 to a low of €188. During this period, we increased our position by
more than 70% at an average price just shy of €200 per share.
This made D'Ieteren our largest position at a 9.3% weight on the 9th December
when the shares closed at €200 per share. On the 10th December the company
traded ex-dividend of the €74 per share special dividend yet closed the day
at €160 i.e. some +27% above the implied ex-dividend price of €126. Net of
10% tax, AGT received proceeds of £35m, equivalent to 3.1% of NAV.
As we look ahead, we expect investors to retune their focus on D'Ieteren's
fundamentals. The last year has seen a relatively difficult operating
environment for Belron, the crown jewel asset that repairs and replaces
vehicle glass, which accounts for 68% of NAV. As higher insurance premiums
have seen customer propensity to repair decline, and the insured market (to
which Belron are more exposed than peers) cede share to the cash market.
During Q3 we saw a number of US auto service peers cut guidance, however
D'Ieteren re-affirmed Belron's guidance, which, in our view, speaks to the
continued and considerable self-help measures the company can utilise. In 2025
we expect D'Ieteren to hold a Capital Markets Day - the first since Carlos
Brito was appointed Belron CEO. We view this and new Belron long-term margin
guidance as key catalysts, which should help re-focus investor attention on
the attractive long-term outlook for the company and its structural tailwinds.
D'Ieteren shares currently trade at €162, which represents an 50% discount
to our estimated NAV. The October 2024 transaction between Belron minority
shareholders at a €32.2bn enterprise value ("EV") pegs D'Ieteren's 50%
equity stake at €221 per D'Ieteren share. This valuation was higher than we
had modelled - having previously estimated Belron to be worth €24.5bn EV, or
17x our estimate for 2024 EBIT. It does however put a line in the sand for
future, more meaningfully sized transactions in Belron's equity, such as an
IPO or further private equity sales. As and when these occur, we expect this
to be a positive catalyst for D'Ieteren's very wide discount to narrow. As
such, despite strong recent performance, D'Ieteren is our second largest
position at 7.4% weight.
Bolloré / Vivendi:
In mid-2023 we (re)initiated a position in Bolloré (4.9% weight) - the French
holding company controlled by Vincent Bolloré. The investment case was
predicated on the attractive NAV growth potential from Universal Music Group
("UMG"); the potential value creation from Vivendi, the French media
conglomerate; and with €6bn of net cash at the holding company level, the
prospect for simplifications across the notoriously complex and deeply
discounted Bolloré group structure. To date returns have been all but zero
(+1.0% ROI).
During the month, Vivendi, of which Bolloré owns just shy of 30%, was split
into four separate companies - Canal+, Havas, Louis Hachette and Vivendi -
with the stated intention to unlock the conglomerate discount at which it
traded. Prima facie this has been ineffective: the four sum of the parts now
trade collectively at €8.2 per share, versus €8.3 the day prior to the
split and €8.0 a little over a year ago when the intention to split up the
group was first announced.
However, from a Bolloré perspective we wonder whether this is not such a bad
thing after all. Having passively moved through 30% in each operating company,
and with more lax shareholder protections, Vincent Bolloré may well exploit
one or more of these undervaluations. Eighteen months ago, it was a consensus
view that Vincent Bolloré would pay a control premium to take over the entire
Vivendi conglomerate. As is often the case, he has dumbfounded fund managers
and avoided putting his hand in his pocket. Ultimately Vincent Bolloré is
motivated by long-term capital gains, not near-term mark to market movements
and we have long been of the view that it makes most sense to be aligned with
him at the Bolloré level, and hence we did not hold a direct position in
Vivendi.
With that said, when surveying the post-split state of play, the valuation of
the remaining Vivendi holding company appears highly attractive, something
that has been compounded by non-fundamental selling from passive investors in
the days following the split. We took advantage of this and built a direct
position such that Vivendi is now an 2.5% weight.
Vivendi's market cap stands at €2.5bn, and its 10% stake in UMG is worth
€4.4bn. Adding in another €2.3bn of listed equity stakes and netting off
€2.1bn of debt brings us to a NAV of €4.7bn and a discount of 46%. To us
it is interesting that this level of discount is wider than the c.40% Vivendi
has averaged in recent years despite Vivendi now being a much simpler beast,
with an entirely listed NAV. Such a level of discount stands out against
liquid European holding companies with listed, hedgeable NAVs, and even more
dramatically so when compared with mono-holding companies - which is now in
essence what Vivendi is. It seems likely to us that Vincent Bollore will want
to monetise and close this discount. In the meantime, this gives us additional
exposure to UMG which underpins an attractive NAV growth outlook.
Contributors / Detractors (in GBP)
Largest Contributors 1- month contribution % Weight
bps
D'Ieteren 113 7.4
Chrysalis Investments 76 7.0
Harbourvest Global 37 5.5
Toyota Industries 32 3.0
Christian Dior 25 2.7
Largest Detractors 1- month contribution % Weight
bps
Entain -57 3.3
News Corp -43 8.3
Frasers Group -30 1.7
Rohto Pharmaceutical -26 4.0
Aker ASA -22 3.6
Link Company Matters Limited
Corporate Secretary
08 January 2025
LEI: 213800QUODCLWWRVI968
The content of the Company's web-pages and the content of any website or pages
which may be accessed through hyperlinks on the Company's web-pages, other
than the content of the Newsletter referred to above, is neither incorporated
into nor forms part of the above announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DOCDZGGMMRNGKZM